Overview

Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the information on safety and efficacy of naratriptan tablets on Japanese subjects with migraine headache during Japanese post-marketing surveillance period.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Naratriptan